
### [MONDO:0016123](http://purl.obolibrary.org/obo/MONDO_0016123)
**Label:** muscular tumor

**Subclasses:** [MONDO:0017386](http://purl.obolibrary.org/obo/MONDO_0017386) (pleomorphic rhabdomyosarcoma), [MONDO:0005212](http://purl.obolibrary.org/obo/MONDO_0005212) (rhabdomyosarcoma (disease)), [MONDO:0009993](http://purl.obolibrary.org/obo/MONDO_0009993) (embryonal rhabdomyosarcoma (disease)), [MONDO:0016824](http://purl.obolibrary.org/obo/MONDO_0016824) (myofibromatosis), 

**Corr. equiv. classes:** [Orphanet:293199](http://www.orpha.net/ORDO/Orphanet_293199), [OMIM:268210](http://purl.obolibrary.org/obo/OMIM_268210), [Orphanet:780](http://www.orpha.net/ORDO/Orphanet_780), [Orphanet:2591](http://www.orpha.net/ORDO/Orphanet_2591), [Orphanet:99757](http://www.orpha.net/ORDO/Orphanet_99757), 

**Class expressions from DL-Learner:**

- [HP:0030448](http://purl.obolibrary.org/obo/HP_0030448) (Soft tissue sarcoma) and (not ([HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe))) 43.57%
- [HP:0030448](http://purl.obolibrary.org/obo/HP_0030448) (Soft tissue sarcoma) and (not ([HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology))) 43.57%
- [HP:0030448](http://purl.obolibrary.org/obo/HP_0030448) (Soft tissue sarcoma) and (not ([HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system))) 43.57%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0030448](http://purl.obolibrary.org/obo/HP_0030448) (Soft tissue sarcoma) 41.32%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) 39.61%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and [HP:0030448](http://purl.obolibrary.org/obo/HP_0030448) (Soft tissue sarcoma) 37.68%
- [HP:0030448](http://purl.obolibrary.org/obo/HP_0030448) (Soft tissue sarcoma) 35.81%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) 33.36%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) 33.36%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) 31.95%
- [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 28.57%
- [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) 28.06%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 24.55%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 24.33%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 23.04%


